"Due to the timing of diagnosis during this critical period of physical, intellectual, and psychosocial development, the higher rate of colectomy, and their longer lifespan without a colon, it is ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
p #60; 0.001. Data from [74]. Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA ...
Visit our podcast page to listen to "Take What Serves. Leave the Rest" and subscribe using your preferred podcast provider. Learn more at takewhatserves.podbean.com. In this episode, Bryan talks to ...
Greater access to innovative treatments could be linked to a drop in patients requiring surgery for a type of inflammatory bowel disease, a 20-year study suggests. The number of patients using ...
What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...
Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...
Here's what colitis is, what leads to it and how the condition is most commonly treated.
An eight-strain probiotic has been shown to reduce the risk for pouchitis in patients with ulcerative colitis who undergo ileal pouch anal anastomosis (IPAA), but its cost-effectiveness depends on ...
NEW YORK A new study led by Mayo Clinic researchers found that ulcerative colitis patients had a 41% reduction in colectomy when treated with infliximab for one year, according to a study published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results